Replay Holdings
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5555 Oberlin Dr Ste 120, San Diego, Cali...Phone Number
(858) 859-2610Website
replay.bioRevenue
$15.2 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Replay Holdings
Replay is a company that operates in the biotechnology industry by reprogramming biology by writing and delivering big DNA.Explore more
Replay Holdings Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Replay Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Replay Holdings has new funding data
Earning: See what the market has to say on Replay Holdings recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Replay Holdings launches new products
Replay Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Replay Holdings had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Replay Holdings
Check if Replay Holdings has recently received funding, and reach out quickly before it becomes old news!
Check out if Replay Holdings is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Replay Holdings as Masked Content
Find 3 more new buyers
Compare Similar Companies to Replay Holdings
Compare insights from companies similar to Replay Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Replay Holdings
$15.2M
11-50
Private
$56.5M
2021
MC
Maria CastnerSenior Vice President and General Counsel
Company Profile Activity
Activity Insights
Replay Holdings is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Replay Holdings is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Replay Holdings.
Replay Holdings financials insights
Gather financial insights about Replay Holdings, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$55M
Grant
$1.5M
Replay Holdings Tech Stack
A closer look at the technologies used by Replay Holdings
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Partnership
Partnership, Product Management, Intellectual Property
Partnership
Partnership, Product Development, Product Management, Intellectual Property
New Hire
Executive Move
New Hire
Executive Move
Replay Holdings News & Media
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myelomaReplay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigensReplay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for multiple myeloma
Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for multiple myeloma
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Replay Holdings
Sign Up For FreeTo access detailed company insights
Replay is a company that operates in the biotechnology industry by reprogramming biology by writing and delivering big DNA.... Read More
